OpenLB
Open Library of Bioscience
Advanced Search
British journal of clinical pharmacology
Oct, 1998;46 (4): 307-19.

Therapeutic drug monitoring: antiarrhythmic drugs.

T J Campbell, K M Williams
Author Information
  1. T J Campbell: Department of Clinical Pharmacology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
PMID: 9803978 DOI: 10.1046/j.1365-2125.1998.t01-1-00768.x

Abstract

Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action. Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast-inward sodium channel on myocardium. These agents have a very significant toxicity, and while they are being used less, therapeutic drug monitoring (TDM) does significantly increase the safety with which they can be administered. Class II agents are antisympathetic drugs, particularly the beta-adrenoceptor blockers. These are generally safe agents which do not normally require TDM. Class III antiarrhythmic agents include sotalol and amiodarone. TDM can be useful in the case of amiodarone to monitor compliance and toxicity but is generally of little value for sotalol. Class IV antiarrhythmic drugs are the calcium channel blockers verapamil and diltiazem. These are normally monitored by haemodynamic effects, rather than using TDM. Other agents which do not fall neatly into the Vaughan Williams classification include digoxin and perhexiline. TDM is very useful for monitoring the administration (and particularly the safety) of both of these agents.

References

  1. Br Med J (Clin Res Ed). 1981 Jul 4;283(6283):58 [PMID: 6788267]
  2. Eur J Clin Pharmacol. 1988;34(3):233-9 [PMID: 3396618]
  3. Arzneimittelforschung. 1988 Mar;38(3):408-11 [PMID: 3382466]
  4. Am J Cardiol. 1985 Mar 1;55(6):807-12 [PMID: 3919554]
  5. J Chromatogr. 1980 Jul 11;183(1):65-71 [PMID: 7400265]
  6. Aust N Z J Med. 1990 Jun;20(3):275-82 [PMID: 2196873]
  7. Circulation. 1971 Feb;43(2):205-11 [PMID: 5540706]
  8. J Chromatogr. 1984 Feb 10;305(2):401-9 [PMID: 6707167]
  9. Am Heart J. 1984 Jan;107(1):143-6 [PMID: 6691222]
  10. Circulation. 1990 Oct;82(4):1106-16 [PMID: 2144796]
  11. Eur Heart J. 1993 Oct;14 Suppl F:18-25 [PMID: 7903243]
  12. Am J Cardiol. 1984 Jan 15;53(2):329-30 [PMID: 6695731]
  13. Br J Clin Pharmacol. 1986 Mar;21(3):319-21 [PMID: 3964531]
  14. J Pharmacol Exp Ther. 1968 Dec;164(2):317-25 [PMID: 5699093]
  15. Clin Pharmacol Ther. 1981 Jun;29(6):729-36 [PMID: 7226704]
  16. Am J Cardiol. 1984 Jan 1;53(1):77-83 [PMID: 6362387]
  17. Ther Drug Monit. 1991 Jan;13(1):86 [PMID: 1905431]
  18. Circulation. 1956 Oct;14(4 Part 1):568-83 [PMID: 13365063]
  19. Ther Drug Monit. 1996 Apr;18(2):168-78 [PMID: 8721281]
  20. Eur Heart J. 1984 Feb;5(2):115-25 [PMID: 6144546]
  21. Clin Chem. 1991 Jan;37(1):94-8 [PMID: 1988216]
  22. J Int Med Res. 1976;4(1 Suppl):5-7 [PMID: 193744]
  23. Pharmacol Rev. 1992 Sep;44(3):377-99 [PMID: 1332083]
  24. Pharm Weekbl Sci. 1989 Jun 23;11(3):92-4 [PMID: 2505226]
  25. Circulation. 1987 Apr;75(4):785-91 [PMID: 3829342]
  26. Ther Drug Monit. 1996 Feb;18(1):65-72 [PMID: 8848824]
  27. Ther Drug Monit. 1989 Nov;11(6):708-11 [PMID: 2512696]
  28. Circulation. 1991 Oct;84(4):1831-51 [PMID: 1717173]
  29. J Pharm Sci. 1981 Mar;70(3):320-2 [PMID: 7264901]
  30. Drug Metab Dispos. 1988 Nov-Dec;16(6):858-64 [PMID: 2907466]
  31. Clin Pharmacol Ther. 1989 Nov;46(5):584-90 [PMID: 2510963]
  32. Arch Mal Coeur Vaiss. 1966 Feb;59(2):263-72 [PMID: 4956181]
  33. J Chromatogr. 1983 Apr 8;273(2):379-92 [PMID: 6863450]
  34. J Pharmacokinet Biopharm. 1979 Jun;7(3):303-11 [PMID: 480151]
  35. Cardiovasc Drugs Ther. 1992 Feb;6(1):11-4 [PMID: 1533532]
  36. Clin Pharmacokinet. 1991 Jul;21(1):1-10 [PMID: 1914339]
  37. Br J Clin Pract. 1976 Sep;30(9):172-7 [PMID: 826264]
  38. J Pharm Sci. 1985 Apr;74(4):460-5 [PMID: 3999009]
  39. Am J Cardiol. 1980 Sep;46(3):463-8 [PMID: 6158263]
  40. Aust N Z J Med. 1996 Oct;26(5):707-8 [PMID: 8958370]
  41. J Pharmacokinet Biopharm. 1979 Feb;7(1):29-46 [PMID: 458555]
  42. Clin Pharmacol Ther. 1975 Jun;17(6):722-30 [PMID: 237647]
  43. Prog Cardiovasc Dis. 1988 Sep-Oct;31(2):115-72 [PMID: 3047813]
  44. J Chromatogr. 1984 Dec 12;336(2):313-9 [PMID: 6530463]
  45. J Am Coll Cardiol. 1984 Jul;4(1):111-6 [PMID: 6736437]
  46. Aust N Z J Med. 1996 Oct;26(5):689-96 [PMID: 8958366]
  47. Drug Intell Clin Pharm. 1982 Sep;16(9):693-5 [PMID: 7128461]
  48. Br J Clin Pharmacol. 1980 Jun;9(6):614-8 [PMID: 7387819]
  49. Cardiovasc Drugs Ther. 1992 Oct;6(5):519-28 [PMID: 1333276]
  50. J Chromatogr. 1986 Sep 5;381(2):305-14 [PMID: 3760088]
  51. J Am Coll Cardiol. 1985 Jan;5(1):108-12 [PMID: 3964797]
  52. J Pharmacol Exp Ther. 1973 Jul;186(1):31-6 [PMID: 4723312]
  53. J Chromatogr. 1987 Jan 9;385:225-32 [PMID: 3558577]
  54. Eur J Clin Pharmacol. 1990;38(6):579-82 [PMID: 2373132]
  55. DICP. 1991 Jul-Aug;25(7-8):739-41 [PMID: 1949929]
  56. Xenobiotica. 1989 Jun;19(6):677-82 [PMID: 2763576]
  57. Circulation. 1991 Nov;84(5):1977-83 [PMID: 1834365]
  58. Ann Intern Med. 1984 Oct;101(4):462-9 [PMID: 6476633]
  59. Ther Drug Monit. 1987;9(1):104-12 [PMID: 3576654]
  60. Am J Cardiol. 1983 Dec 1;52(10):1208-13 [PMID: 6359849]
  61. J Pharmacokinet Biopharm. 1982 Oct;10(5):465-94 [PMID: 6762414]
  62. Ther Drug Monit. 1987 Sep;9(3):283-91 [PMID: 3672571]
  63. Life Sci. 1980 Sep 29;27(13):1191-7 [PMID: 7421405]
  64. Am J Physiol. 1994 Jan;266(1 Pt 2):F66-75 [PMID: 7905714]
  65. Br Heart J. 1978 Jul;40(7):796-801 [PMID: 687477]
  66. J Chromatogr. 1987 Oct 30;421(2):309-18 [PMID: 3429585]
  67. Biochem Pharmacol. 1996 Jul 26;52(2):273-80 [PMID: 8694852]
  68. JAMA. 1978 Aug 11;240(6):533-4 [PMID: 671662]
  69. Br J Clin Pharmacol. 1993 Jul;36(1):75-7 [PMID: 8373714]
  70. Eur J Clin Pharmacol. 1978 Nov 27;14(3):195-201 [PMID: 729614]
  71. J Pharm Sci. 1990 Feb;79(2):91-5 [PMID: 2109058]
  72. Am J Cardiol. 1990 Jan 2;65(2):74A-81A; discussion 82A-83A [PMID: 2403737]
  73. J Pharmacokinet Biopharm. 1984 Dec;12(6):559-73 [PMID: 6398364]
  74. Pacing Clin Electrophysiol. 1997 Feb;20(2 Pt 2):432-44 [PMID: 9058847]
  75. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):625-9 [PMID: 2505091]
  76. Clin Pharmacol Ther. 1989 Sep;46(3):352-8 [PMID: 2776394]
  77. J Chromatogr. 1987 Apr 10;415(2):335-46 [PMID: 3584372]
  78. Clin Pharmacokinet. 1977 Sep-Oct;2(5):373-83 [PMID: 21054]
  79. Ann Intern Med. 1986 Jul;105(1):64-5 [PMID: 2424355]
  80. Xenobiotica. 1986 May;16(5):491-502 [PMID: 3739369]
  81. Circulation. 1982 May;65(5):886-94 [PMID: 6176355]
  82. Circ Res. 1985 Jun;56(6):857-67 [PMID: 4006095]
  83. Am Heart J. 1982 Apr;103(4 Pt 1):567-9 [PMID: 7064795]
  84. Am Heart J. 1982 Aug;104(2 Pt 1):289-302 [PMID: 7048875]
  85. Br J Clin Pharmacol. 1992 Mar;33(3):275-80 [PMID: 1576047]
  86. Br J Clin Pharmacol. 1989 Nov;28(5):555-66 [PMID: 2511912]
  87. J Pharmacokinet Biopharm. 1976 Jun;4(3):199-230 [PMID: 978389]
  88. Circulation. 1994 May;89(5):2396-400 [PMID: 7910120]
  89. J Med Chem. 1980 Sep;23(9):1044-8 [PMID: 7411548]
  90. Med J Aust. 1993 Jun 7;158(11):732-3 [PMID: 8341184]
  91. Br Med J (Clin Res Ed). 1982 Jan 30;284(6312):295-9 [PMID: 6277419]
  92. Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):272 [PMID: 6779981]
  93. Drug Metab Dispos. 1996 Feb;24(2):142-7 [PMID: 8742224]
  94. J Am Coll Cardiol. 1984 Dec;4(6):1148-63 [PMID: 6209318]
  95. Am Heart J. 1988 Jun;115(6):1274-9 [PMID: 3287873]
  96. Clin Chem. 1992 Dec;38(12):2426-30 [PMID: 1458579]
  97. Ther Drug Monit. 1990 Mar;12(2):195-200 [PMID: 2315977]
  98. N Engl J Med. 1989 Aug 10;321(6):406-12 [PMID: 2473403]
  99. Clin Pharmacol Ther. 1986 May;39(5):530-6 [PMID: 3698461]
  100. Ann Cardiol Angeiol (Paris). 1977 Nov;26 Suppl:493-9 [PMID: 202187]
  101. J Pharm Sci. 1977 Apr;66(4):591-2 [PMID: 856981]
  102. J Pharm Sci. 1984 Oct;73(10):1469-71 [PMID: 6502499]
  103. Am Heart J. 1987 Dec;114(6):1436-44 [PMID: 3687699]
  104. Circulation. 1989 Jul;80(1):34-42 [PMID: 2736754]
  105. Clin Pharmacol Ther. 1975 Jun;17(6):669-76 [PMID: 1139858]
  106. Circulation. 1985 Sep;72(3):555-64 [PMID: 4017207]
  107. Clin Pharmacol Ther. 1990 Jun;47(6):740-6 [PMID: 2162749]
  108. Clin Pharmacol Ther. 1989 May;45(5):542-7 [PMID: 2721110]
  109. Am J Cardiol. 1984 Nov 14;54(9):9D-12D [PMID: 6496371]
  110. Pain. 1987 Jan;28(1):69-75 [PMID: 3822496]
  111. J Pharmacol Exp Ther. 1993 Sep;266(3):1620-5 [PMID: 8103798]
  112. Postgrad Med J. 1977;53 Suppl 1:50-5 [PMID: 876954]
  113. JAMA. 1993 Oct 6;270(13):1589-95 [PMID: 8371471]
  114. J Chromatogr. 1988 Feb 26;424(2):424-9 [PMID: 3372636]
  115. Circulation. 1982 May;65(5):879-85 [PMID: 7074749]
  116. Clin Pharmacol Ther. 1990 Sep;48(3):245-54 [PMID: 2401123]
  117. J Clin Pharmacol. 1984 Apr;24(4):129-47 [PMID: 6144698]
  118. Clin Pharmacol Ther. 1989 May;45(5):562-7 [PMID: 2498026]
  119. J Chromatogr. 1991 Apr 19;565(1-2):523-8 [PMID: 1874902]
  120. Ther Drug Monit. 1984;6(2):192-8 [PMID: 6740739]
  121. Clin Ther. 1983;5(4):357-64 [PMID: 6871920]
  122. Circulation. 1990 Apr;81(4):1260-70 [PMID: 2180591]
  123. J Cardiovasc Pharmacol. 1990 Jan;15(1):75-81 [PMID: 1688986]
  124. Clin Pharmacol Ther. 1976 Mar;19(3):339-51 [PMID: 1261169]
  125. J Pain Symptom Manage. 1991 Jan;6(1):30-9 [PMID: 1988534]
  126. Am Heart J. 1976 Jul;92(1):57-64 [PMID: 785988]
  127. Acta Pharmacol Toxicol (Copenh). 1979 Jul;45(1):52-7 [PMID: 474159]
  128. J Cardiovasc Pharmacol. 1993 Feb;21(2):316-22 [PMID: 7679168]
  129. Am Heart J. 1983 Oct;106(4 Pt 2):840-7 [PMID: 6613830]
  130. Int J Cardiol. 1986 Nov;13(2):219-29 [PMID: 3793279]
  131. Adv Pharmacol. 1991;22:57-135 [PMID: 1958505]
  132. J Pharm Pharmacol. 1991 Sep;43(9):630-5 [PMID: 1685521]
  133. Ann Intern Med. 1969 Nov;71(5):927-33 [PMID: 5360313]
  134. J Am Coll Cardiol. 1986 Jul;8(1 Suppl A):104A-109A [PMID: 2423571]
  135. N Engl J Med. 1993 Apr 29;328(17):1244-51 [PMID: 7681934]
  136. J Pharmacokinet Biopharm. 1986 Aug;14(4):335-56 [PMID: 3772736]
  137. Arzneimittelforschung. 1995 May;45(5):542-5 [PMID: 7612052]
  138. Br J Pharmacol. 1987 Sep;92(1):97-103 [PMID: 3664094]
  139. N Engl J Med. 1983 Nov 24;309(21):1302-6 [PMID: 6633588]
  140. J Am Coll Cardiol. 1988 Jul;12(1):131-9 [PMID: 3379198]
  141. N Engl J Med. 1992 Jul 23;327(4):227-33 [PMID: 1377359]
  142. Br J Clin Pharmacol. 1986 May;21(5):481-7 [PMID: 3718807]
  143. Ann Intern Med. 1980 Nov;93(5):701-4 [PMID: 7212479]
  144. J Pharm Sci. 1990 Mar;79(3):257-60 [PMID: 2110973]
  145. J Clin Pharmacol. 1989 May;29(5):436-8 [PMID: 2661603]

MeSH Term

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Calcium Channel Blockers
Catecholamines
Drug Monitoring
Humans
Potassium Channel Blockers
Sodium Channel Blockers

Chemicals

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Calcium Channel Blockers
Catecholamines
Potassium Channel Blockers
Sodium Channel Blockers
Journal Article Review
Article has an altmetric score of 3

Word Cloud

Created with Highcharts 10.0.0agentsTDMClassantiarrhythmicdrugsincludetraditionallyVaughanWilliamsactionchanneltoxicitydrugmonitoringsafetycanparticularlyblockersgenerallynormallysotalolamiodaroneusefulAntiarrhythmicclassifiedaccordingfourclassesthoughtantiarrhythmicscommonblockadefast-inwardsodiummyocardiumsignificantusedlesstherapeuticsignificantlyincreaseadministeredIIantisympatheticbeta-adrenoceptorsaferequireIIIcasemonitorcompliancelittlevalueIVcalciumverapamildiltiazemmonitoredhaemodynamiceffectsratherusingfallneatlyclassificationdigoxinperhexilineadministrationTherapeuticmonitoring:

Similar Articles

Cited By (18)